One Drop, Fitbit partner for diabetes management data insights

One Drop, a digital diabetes self-management platform, will partner with Fitbit to provide data-driven care management tools to those living with diabetes.

The partnership will incorporate Fitbit data into the One Drop mobile app for insights into how exercise affects blood glucose levels to improve diabetes self-management. Additionally, Fitbit data will be utilized by One Drop | Experts and One Drop | Professional users for research into developing personalized care decisions.

"We strive to provide our community with the most comprehensive set of data and tools to manage their diabetes or prediabetes. Working with Fitbit, the leading global wearables brand, was a natural next step for One Drop," said Jeff Dachis, CEO and founder of One Drop. "One Drop is among the top Health and Fitness apps in nearly 120 countries with over 600,000 downloads worldwide. By integrating Fitbit data and creating an app for Fitbit Ionic, we will be able to provide our users and their healthcare providers with more data and deeper insights to better manage their diabetes."

One Drop uses can sync their Fitbit to their One Drop accounts for free access to daily information, so they can make more informed self-care decisions. The cloud-based diabetes platform continuously updates with the users Fitbit data, providing an accurate account of data for users to evaluate.

"Our mission is to help make the world healthier, and our new Ionic smartwatch is the health platform that allows us to deliver our most advanced health and fitness features to the market," said Adam Pellegrini, general manager of Fitbit Health Solutions. "This holistic experience brings the power of Fitbit data together with One Drop's sophisticated care management technology to provide meaningful insights on the role of physical activity and how it can improve the health of those living with diabetes."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.